Company Filing History:
Years Active: 2012-2013
Title: Chris Cheeseman: Innovator in Radiopharmaceuticals
Introduction
Chris Cheeseman is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of radiopharmaceuticals, particularly in the development of fructose-based compounds for medical imaging.
Latest Patents
Chris Cheeseman holds 2 patents related to his innovative work. His latest patents include "Fluorinated fructose derivatives for PET imaging." This invention is directed to fructose-based radiopharmaceuticals, pharmaceutical compositions comprising the same, precursors and methods for preparing them, as well as methods of using them for diagnostic imaging of cancer cells and non-imaging tracer studies.
Career Highlights
Chris Cheeseman is affiliated with the University of Alberta, where he continues to advance research in his field. His work has the potential to significantly impact cancer diagnostics and treatment.
Collaborations
Some of his notable coworkers include Frederick West and Tina Grant, who contribute to the collaborative research environment at the University of Alberta.
Conclusion
Chris Cheeseman's innovative work in radiopharmaceuticals exemplifies the importance of research in advancing medical technology. His contributions are paving the way for improved diagnostic methods in cancer treatment.